Phreesia, Inc. Stock News

Phreesia, Inc. (NYSE:PHR ) Q2 2024 Earnings Conference Call September 6, 2023 5:00 PM ET Company Participants Chaim Indig - Chief Executive Officer Balaji Gandhi - Chief Financial Officer Conference C

Phreesia (PHR) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.89 per share a year ago.

Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The consensus price target hints at a 27.3% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate

Phreesia, Inc. provides a suite of patient care software and services to healthcare providers in the U.S. and Canada. Management recently guided to slower top line revenue growth in fiscal 2024 than f

I reiterate a buy rating for PHR due to its strong execution and consistent addition of new logos, despite the uncertain environment. PHR's conservative forecast for FY24 suggests potential for exceed

Phreesia, Inc. (NYSE:PHR ) Q1 2024 Results Conference Call May 31, 2023 5:00 PM ET Company Participants Balaji Gandhi - CFO Chaim Indig - CEO Conference Call Participants Anne Samuel - JPMorgan Ryan D

While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended April 2023, it could be worth looking at how some of its key metrics compare t

Phreesia (PHR) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.99 per share a year ago.

Phreesia, Inc. (PHR) Q4 2023 Earnings Conference Call March 22, 2023 5:00 PM ET Corporate Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer C

Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength do

Founders-led PHR has been adding clinics and patients to its ecosystem. The newly added clinics are smaller in scale, signaling the end of rapid market penetration.

Phreesia, Inc. (NYSE:PHR ) Q3 2023 Earnings Conference Call December 8, 2022 5:00 PM ET Company Participants Balaji Gandhi - SVP, IR Chaim Indig - CEO & Co-Founder Randy Rasmussen - CFO Conference Cal